World Top 100 Biopharmaceutical Companies List by Market Cap as of August 2026

World Top 100 Biopharmaceutical Companies List by Market Cap as of August 2026, World Biggest 100 Biopharmaceutical Companies by Market Cap, World Largest 100 Biopharmaceutical Companies in the World by market cap as of August 2026.

World Top Biopharmaceutical Companies 2026
World Largest Biopharmaceutical Companies by Market Cap in 2026, World Top Biopharmaceutical Companies by Market Cap in 2026.

  1. ATAI Life Sciences N.V.

    World Rank (Aug-2026)
    5,361
    Market Cap (Aug-2026)
    2.692 Billion USD
    World Rank (Jan-05-2024)
    16,036
    Market Cap (Jan-05-2024)
    0.286 Billion USD
    World Rank (Jul-30-2023)
    15,102
    Market Cap (Jul-30-2023)
    0.342 Billion USD
    World Rank (Dec-25-2022)
    13,197
    Market Cap (Dec-25-2022)
    0.443 Billion USD
    World Rank (Jan-07-2022)
    9,233
    Market Cap (Jan-07-2022)
    1.03 Billion USD
    Headquarters Country
    Germany
    Yahoo @ Nasdaq
    Company Profile
    Atai is a biopharmaceutical company that leverages a decentralised platform approach to incubate and accelerate the development of highly effective mental health treatments that address the unmet needs of patients. Headquarters is in Germany.
    Company Website
    ATAI LIFE SCIENCES N.V.

  2. Ultragenyx Pharmaceutical

    World Rank (Aug-2026)
    5,466
    Market Cap (Aug-2026)
    2.612 Billion USD
    World Rank (Jan-05-2024)
    3,549
    Market Cap (Jan-05-2024)
    3.941 Billion USD
    World Rank (Jul-30-2023)
    4,303
    Market Cap (Jul-30-2023)
    3.053 Billion USD
    World Rank (Dec-25-2022)
    4,035
    Market Cap (Dec-25-2022)
    3.051 Billion USD
    World Rank (Jan-07-2022)
    3,267
    Market Cap (Jan-07-2022)
    5.03 Billion USD
    Annual Revenue in USD
    673 Million USD
    Annual Operating Income in USD
    -535 Million USD
    Annual Net Income in USD
    -575 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Ultragenyx Pharmaceutical is a Clinical Stage Biopharmaceutical company. It committed to bringing to patients novel products for the treatment of rare and ultra rare diseases with a focus on serious debilitating genetic diseases. The company portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need and clear biology for which there are no approved therapies. The headquarters is in USA.

    Company Website
    ULTRAGENYX PHARMACEUTICAL INC

  3. Kodiak Sciences

    World Rank (Aug-2026)
    5,488
    Market Cap (Aug-2026)
    2.588 Billion USD
    World Rank (Jan-05-2024)
    19,085
    Market Cap (Jan-05-2024)
    0.160 Billion USD
    World Rank (Jul-30-2023)
    19,561
    Market Cap (Jul-30-2023)
    0.150 Billion USD
    World Rank (Dec-25-2022)
    14,429
    Market Cap (Dec-25-2022)
    0.368 Billion USD
    World Rank (Jan-07-2022)
    4,108
    Market Cap (Jan-07-2022)
    3.74 Billion USD
    Annual Operating Income in USD
    -234 Million USD
    Annual Net Income in USD
    -230 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Kodiak Sciences is a Clinical Stage Biopharmaceutical company. It is specializing in novel therapeutics to treat chronic and high prevalence ophthalmic diseases. The headquarters is in USA.

    Company Website
    KODIAK SCIENCES

  4. Nektar Therapeutics

    World Rank (Aug-2026)
    5,639
    Market Cap (Aug-2026)
    2.467 Billion USD
    World Rank (Jan-05-2024)
    21,027
    Market Cap (Jan-05-2024)
    0.108 Billion USD
    World Rank (Jul-30-2023)
    21,502
    Market Cap (Jul-30-2023)
    0.103 Billion USD
    World Rank (Dec-25-2022)
    13,797
    Market Cap (Dec-25-2022)
    0.404 Billion USD
    World Rank (Jan-07-2022)
    5,673
    Market Cap (Jan-07-2022)
    2.34 Billion USD
    Annual Revenue in USD
    55 Million USD
    Annual Operating Income in USD
    -140 Million USD
    Annual Net Income in USD
    -164 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Nektar Therapeutics is a research based development stage Biopharmaceutical company. It R&D pipeline of new investigational drugs includes treatments for cancer and auto immune disease and leverage Nektar's proprietary and proven chemistry platform in the discovery and design of new drug candidates. The headquarters is in USA.
    Company Website
    NEKTAR THERAPEUTICS
    Wikipedia
    Wikipedia

  5. Amylyx Pharmaceuticals Inc.

    World Rank (Aug-2026)
    5,709
    Market Cap (Aug-2026)
    2.410 Billion USD
    World Rank (Jan-05-2024)
    8,008
    Market Cap (Jan-05-2024)
    1.123 Billion USD
    World Rank (Jul-30-2023)
    6,840
    Market Cap (Jul-30-2023)
    1.514 Billion USD
    World Rank (Dec-25-2022)
    4,858
    Market Cap (Dec-25-2022)
    2.356 Billion USD
    World Rank (Jan-07-2022)
    8,733
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -153 Million USD
    Annual Net Income in USD
    -145 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Company Profile
    Amylyx Pharmaceuticals Inc is a pharmaceutical company that is dedicated to the development of potential therapies for neurodegenerative diseases. The headquarters is in United States.
    Company Website
    AMYLYX PHARMACEUTICALS, INC.

  6. Vericel Corporation

    World Rank (Aug-2026)
    5,928
    Market Cap (Aug-2026)
    2.263 Billion USD
    World Rank (Jan-05-2024)
    6,459
    Market Cap (Jan-05-2024)
    1.623 Billion USD
    World Rank (Jul-30-2023)
    6,143
    Market Cap (Jul-30-2023)
    1.797 Billion USD
    World Rank (Dec-25-2022)
    7,816
    Market Cap (Dec-25-2022)
    1.125 Billion USD
    World Rank (Jan-07-2022)
    6,909
    Market Cap (Jan-07-2022)
    1.71 Billion USD
    Annual Revenue in USD
    276 Million USD
    Annual Operating Income in USD
    11 Million USD
    Annual Net Income in USD
    17 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Bio pharmaceutical company with headquarters is in USA.
    Company Website
    VERICEL

  7. Harmony Biosciences Holdings Inc.

    World Rank (Aug-2026)
    5,989
    Market Cap (Aug-2026)
    2.220 Billion USD
    World Rank (Jan-05-2024)
    5,928
    Market Cap (Jan-05-2024)
    1.871 Billion USD
    World Rank (Jul-30-2023)
    5,534
    Market Cap (Jul-30-2023)
    2.111 Billion USD
    World Rank (Dec-25-2022)
    3,759
    Market Cap (Dec-25-2022)
    3.363 Billion USD
    World Rank (Jan-07-2022)
    5,877
    Market Cap (Jan-07-2022)
    2.22 Billion USD
    Annual Revenue in USD
    868 Million USD
    Annual Operating Income in USD
    208 Million USD
    Annual Net Income in USD
    159 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Harmony Biosciences Holdings is a Pharmaceutical company. It focuses on disorders of sleep and wakefulness and currently working to advance the understanding of narcolepsy and provide information and resources to people who live with and healthcare professionals who treat, this chronic, debilitating neurologic disorder. The headquarters is in USA.

    Facts About Company

    The company annual revenue was 437 million USD and net income was 181 million USD as on 2022.

    Company Website
    HARMONY BIOSCIENCES HOLDINGS, INC.

  8. Nuvation Bio Inc.

    World Rank (Aug-2026)
    6,043
    Market Cap (Aug-2026)
    2.184 Billion USD
    World Rank (Jan-05-2024)
    15,248
    Market Cap (Jan-05-2024)
    0.327 Billion USD
    World Rank (Jul-30-2023)
    14,372
    Market Cap (Jul-30-2023)
    0.385 Billion USD
    World Rank (Dec-25-2022)
    14,104
    Market Cap (Dec-25-2022)
    0.387 Billion USD
    World Rank (Jan-07-2022)
    7,508
    Market Cap (Jan-07-2022)
    1.47 Billion USD
    Annual Revenue in USD
    63 Million USD
    Annual Operating Income in USD
    -213 Million USD
    Annual Net Income in USD
    -205 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Company Profile

    Nuvation Bio is a Biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. The headquarters is in USA.

    Company Website
    NUVATION BIO INC.

  9. HUTCHMED (China) Limited

    World Rank (Aug-2026)
    6,047
    Market Cap (Aug-2026)
    2.183 Billion USD
    World Rank (Jan-05-2024)
    4,247
    Market Cap (Jan-05-2024)
    3.124 Billion USD
    Headquarters Country
    Hong Kong
    Yahoo @ Nasdaq
    Company Profile

    HUTCHMED is an innovative, commercial-stage biopharmaceutical company and developing targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The headquarters is in Hong Kong.

    Company Website
    HUTCHMED (China) Limited

  10. Pharma Mar

    World Rank (Aug-2026)
    6,162
    Market Cap (Aug-2026)
    2.102 Billion USD
    World Rank (Jan-05-2024)
    9,684
    Market Cap (Jan-05-2024)
    0.816 Billion USD
    World Rank (Jul-30-2023)
    10,987
    Market Cap (Jul-30-2023)
    0.662 Billion USD
    World Rank (Dec-25-2022)
    7,221
    Market Cap (Dec-25-2022)
    1.288 Billion USD
    World Rank (Jan-07-2022)
    8,857
    Market Cap (Jan-07-2022)
    1.11 Billion USD
    Annual Revenue in USD
    229 Million USD
    Annual Net Income in USD
    92 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Spain
    Yahoo @ Spain
    Company Profile
    Pharma Mar is a biopharmaceutical company focused on anti cancer drugs based on marine invertebrates. The company annual revenue is 269.9 million EUR, annual operating income is 155.9 million EUR, annual net income is 137.2 million EUR and total assets are 330 million EUR as on 2020. The headquarters is in Spain.
    Company Website
    PHARMA MAR

Share